menu
    • menu

    Company profile for Juvena Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our technical innovations integrate and expand the latest approaches in Proteomics, Transcriptomics, computer vision, Natural Language Processing (NLP), Quantitative Structure Activity Relationship (QSAR) modeling, and neural networks to build an ML-enhanced drug discovery platform. With our Deep Learning predictive modeling, we can identify and rank lead therapeutic candidates more cost-effectively and much quicker than tradi...
    Our technical innovations integrate and expand the latest approaches in Proteomics, Transcriptomics, computer vision, Natural Language Processing (NLP), Quantitative Structure Activity Relationship (QSAR) modeling, and neural networks to build an ML-enhanced drug discovery platform. With our Deep Learning predictive modeling, we can identify and rank lead therapeutic candidates more cost-effectively and much quicker than traditional methods.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Juvena TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Palo Alto, CA 94304
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.juvenatherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jefferson River Launches New Life Sciences Investment Fund
    Jefferson River Launches New Life Sciences Investment Fund

    08 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-08/jefferson-river-capital-launches-new-life-sciences-investment-fund-jefferson-life-sciences

    PHARMIWEB
    08 Oct 2025
    Share Share
    Eli Lilly Works out $650 M Juvena Pact to Muscle-Boosting Drugs
    Eli Lilly Works out $650 M Juvena Pact to Muscle-Boosting Drugs

    12 Jun 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/eli-lilly-works-out-650m-juvena-pact-find-muscle-boosting-drugs

    FIERCE BIOTECH
    12 Jun 2025
    Share Share
    Juvena Therapeutics Starts First-in-Human Trial of JUV-161
    Juvena Therapeutics Starts First-in-Human Trial of JUV-161

    19 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/19/3083992/0/en/Juvena-Therapeutics-Announces-Initiation-of-First-in-Human-Clinical-Trial-of-JUV-161.html

    GLOBENEWSWIRE
    19 May 2025
    Share Share
    Juvena Therapeutics Receives FDA Orphan Drug Designation for JUV-161
    Juvena Therapeutics Receives FDA Orphan Drug Designation for JUV-161

    23 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240123210304/en

    BUSINESSWIRE
    23 Jan 2024
    Share Share
    Juvena Therapeutics Bolsters Leadership Team With Key Industry Veterans
    Juvena Therapeutics Bolsters Leadership Team With Key Industry Veterans

    25 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230125005329/en

    BUSINESSWIRE
    25 Jan 2023
    Share Share
    Juvena Therapeutics Secures $41 M to Accelerate the Discovery and Development
    Juvena Therapeutics Secures $41 M to Accelerate the Discovery and Development

    08 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221108005193/en

    BUSINESSWIRE
    08 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search